Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer
NA
This clinical trial studies fludarabine phosphate, low-dose total body irra...
A Novel Sequential Treatment of Salvage and Reduced Intensity Conditioning (RIC) Chemotherapy for Allogeneic Stem-Cell Transplantation (SCT) for Primary Refractory and Relapsed Acute Myelogenous Leukemia (AML)
PHASE1
This open-label Phase I study is designed to determine the maximum tolerate...
Genetically Modified T-cell Infusion Following Peripheral Blood Stem Cell Transplant in Treating Patients With Recurrent or High-Risk Non-Hodgkin Lymphoma
PHASE1
This phase I trial studies the side effects and best dose of genetically mo...
Comparison of Quality of Life in Patients Undergoing More Intensive Versus Less Intensive Chemotherapy and Radiation Preceding a Bone Marrow Transplant
N/A
This study will examine the quality of life of patients undergoing bone mar...
Status
Completed
Location
Warren G. Magnuson Clinical Center (CC)
Start Date
1999-10
Trial ID
NCT00004994
Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation Followed by Donor Bone Marrow Transplant and Cyclophosphamide, Mycophenolate Mofetil, Tacrolimus, and Sirolimus in Treating Patients With Primary Immunodeficiency Disorders or Noncancerous Inherited Disorders
PHASE2
This phase I/II trial studies the side effects of fludarabine phosphate, cy...
Combination Chemotherapy, Total-Body Irradiation, Peripheral Stem Cell Transplantation, and Lymphocyte Infusion in Treating Patients With Stage IV Melanoma
PHASE2
RATIONALE: Drugs used in chemotherapy such as fludarabine use different way...